Aurinia Pharmaceuticals Inc. (AUPH) Operating margin 2018–2025
Aurinia Pharmaceuticals Inc. (AUPH) operating margin by fiscal year — reported operating income divided by reported revenue.
37.1%FY2025 · since FY2018: -11930.9% → 37.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 37.1% | +39.1 pp |
| FY2024 | -2.0% | +50.2 pp |
| FY2023 | -52.2% | +30.9 pp |
| FY2022 | -83.2% | +313.1 pp |
| FY2021 | -396.3% | -188.2 pp |
| FY2020 | -208.1% | +28390.3 pp |
| FY2019 | -28598.4% | -16667.5 pp |
| FY2018 | -11930.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice